Allergy Immuno Technologies Incorporated Company Profile

06:52 EDT 24th June 2018 | BioPortfolio

Allergy Immuno Technologies, Inc. (AIT) and its predecessors commenced development activities in allergy and immune disorder research diagnostic reagents and services in 1980. AIT currently operates a clinical reference laboratory at 1527 Monrovia Avenue, Newport Beach, CA, for allergy and other diagnostic testing services for physicians, other laboratories and pharmaceutical companies.

As a result of its research activities, AIT has discovered new methods for treating allergies. AIT has succeeded in obtaining the rights to four patents pertaining to its discoveries for allergy treatment. These are:

Immunotherapy agents for treatment of IgE mediated allergies.

Liposome containing immunotherapy agents for treatment of IgE mediated allergies.

Immunotherapy agents for treatment of IgE mediated allergies.

Allergen-thymic hormone conjugates for treatment of IgE mediated allergies.


1527 Monrovia Avenue
Newport Beach
United States of America


Phone: 714 645 3703
Fax: 714 722 6674

News Articles [923 Associated News Articles listed on BioPortfolio]

DBV Technologies Reports Positive Data from Milk Allergy Trial

French company DBV Technologies is seeing some positive results from its milk allergy treatment.

This Immunotherapy Could Be The First to Treat Milk Allergy in Children

DBV Technologies has shown in a Phase II trial that its skin patch could desensitize over 60% of children with strong milk allergy. DBV Technologies, one of the largest public biotechs in France, is ...

DBV Technologies’ Milk Allergy Patch Helps Kids in a Phase II Trial

DBV Technologies’ candidate could be the first treatment for allergies to cow milk after its Viaskin Milk skin patch achieved positive Phase II results. DBV Technologies is developing a skin pat...

DBV shares jump as peanut allergy patch heads to filing

Eight years on from its first U.S. clinical trial, DBV Technologies' immunotherapy patch to combat peanut allergy could be submitted for U.S. approval in the second half of 2018.

DBV and Aimmune poised to dominate peanut allergy market

Last week, the top two contenders for first peanut allergy immunotherapy to market—DBV Technologies and Aimmune Therapeutics—presented to investors at...Read More... The post DBV and Aimmune poise...

Horizon Discovery enters agreement with immuno-oncology company

Horizon Discovery Group, specialists in gene editing and gene modulation technologies, has entered into a non-exclusive out-licensing agreement with a US-based immuno-oncology therapeutics developer f...

DBV Technologies nets $55.6mm through public ADS sale

DBV Technologies SA (allergy immunotherapies) netted $55.6mm through a public global offering of 2.78mm American Depositary Shares (representing 1.4mm ordinary shares) at $21.26 per ADS. Proceeds will...

Japanese cedar allergy drug reimbursed in Japan

Allergy specialist ALK has announced that reimbursement has been agreed for its sublingual allergy immunotherapy…

PubMed Articles [1196 Associated PubMed Articles listed on BioPortfolio]

A Retrospective Critical Analysis and Risk Stratification of Penicillin Allergy De-labelling in a UK Specialist Regional Allergy Service.

A spurious label of penicillin allergy (Pen-A) negatively impacts on antibiotic stewardship and healthcare costs. Recent studies have proposed a guideline-steered direct penicillin challenge without u...

Anaphylaxis by exclusive allergy to swordfish and identification of a new fish allergen.

Fish allergy affects up to 7% of the worldwide population, with variations between countries mostly stemming from consumption rates and methods of allergy diagnosis. In Spain, where fish consumption i...

Predictors of Persistent Wheat Allergy in Children: A Retrospective Cohort Study.

Wheat allergy is the third most common food allergy that develops during infancy in Japan. To identify factors associated with persistent wheat allergy, we assessed the rate of tolerance acquisition a...

Efficacy and safety of five-day challenge for the evaluation of non-severe amoxicillin allergy in children.

Penicillin allergy is the most frequent drug allergy, among which aminopenicillins are reputed for causing delayed rashes in children, particularly in the context of viral infections. Despite a negati...

The Genetics of Food Allergy.

Food allergy likely arises from a complex interplay between environmental triggers and genetic susceptibility. Here, we review recent studies that have investigated the genetic pathways and mechanisms...

Clinical Trials [1681 Associated Clinical Trials listed on BioPortfolio]

The Effect of Per Oral Immunotherapy in Severe Milk, Peanut and Egg Allergy in Adults

The aim is to analyse the results of per oral immunotherapy treatment in severe milk, peanut or egg allergy in adults. This is the second part of the oral immunotherapy study in adults at ...

Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

The purpose of this research study is to find out if cat allergy shots with combination with AMG 157, an experimental medication, will help the cat allergy shots work after just one year o...

Sublingual Milk Immunotherapy in Children

Sublingual immunotherapy is developing in the treatment of aeroallergens allergy. The hypothesis is that such process may be applied to food allergy, more precisely to milk. A previous se...

Predictors of Positive Food Challenge

Patients with suspected tree-nut or sesame allergy based on sensitization on skin-prick tests (SPT), will be assessed for allergy using component analysis and basophil activation test (BAT...

Allergy Immunotherapy for the Reduction of Asthma

In this clinical study we aim to determine the effect of allergy immunotherapy in decreasing asthma and allergy related disease in children who had multiple episodes of wheezing and who ar...

Companies [1529 Associated Companies listed on BioPortfolio]

Allergy Immuno Technologies Incorporated

Allergy Immuno Technologies, Inc. (AIT) and its predecessors commenced development activities in allergy and immune disorder research diagnostic reagents and services in 1980. AIT currently operates a...

Allergy Technologies LLC

Allergy Technologies LLC is committed to the creation and manufacture of innovative, effective and consumer-friendly products addressing major issues in both pest control and heal...

Planet Technologies

On March 9, 2005, Planet announced a definitive agreement to acquire privately-owned Allergy Control Products. The combination of Planet’s Allergy Free business with Allergy Control will create one ...

Biomerica Incorporated

Biomerica is a global medical company founded in 1971 with a mission to significantly improve the lives of individuals with chronic illness while lowering the overall cost of healthcare. Our operation...

Allergy Cure

Allergies like food allergies i.e. Peanut allergy wheat allergy milk allergy dog allergies cat allergies latex allergy skin allergies dust mites allergy cure by Aller-X herbal Medicine admark herba...

More Information about "Allergy Immuno Technologies Incorporated" on BioPortfolio

We have published hundreds of Allergy Immuno Technologies Incorporated news stories on BioPortfolio along with dozens of Allergy Immuno Technologies Incorporated Clinical Trials and PubMed Articles about Allergy Immuno Technologies Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allergy Immuno Technologies Incorporated Companies in our database. You can also find out about relevant Allergy Immuno Technologies Incorporated Drugs and Medications on this site too.

Quick Search


Relevant Topics

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Corporate Database Quicklinks

Searches Linking to this Company Record